01.10.2011 • News • Momenta Pharmaceuticals • Watson Pharmaceuticals

Momenta Files for Injunction Against Amphastar, Watson and Int'l Medical Systems

 

Momenta Pharmaceuticals announced that it has filed a request for a temporary restraining order and preliminary injunction to prevent Amphastar Pharmaceuticals, Watson Pharmaceuticals and International Medical Systems from launching their enoxaparin sodium product in the United States.

On September 21, 2011 Momenta announced that it had sued Amphastar, Watson, and International Medical Systems in the United States District Court for the District of Massachusetts for infringement of two Momenta patents.

The patents cover the company's methods of producing enoxaparin sodium.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature